Invention Grant
- Patent Title: Conserved HBV and HCV sequences useful for gene silencing
- Patent Title (中): 保守的HBV和HCV序列可用于基因沉默
-
Application No.: US14043272Application Date: 2013-10-01
-
Publication No.: US09200281B2Publication Date: 2015-12-01
- Inventor: Catherine J Pachuk , Chandrasekhar Satishchandran , Vincent R. Zurawski , Liat Mintz
- Applicant: ALNYLAM PHARMACEUTICALS, INC.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Nixon Peabody LLP
- Agent Mark J. FitzGerald; David S. Resmick
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K48/00 ; A61K31/713
Abstract:
Conserved consensus sequences from known hepatitis B virus strains and known hepatitis C virus strains, which are useful in inhibiting the expression of the viruses in mammalian cells, are provided. These sequences are useful to silence the genes of HBV and HCV, thereby providing therapeutic utility against HBV and HCV viral infection in humans.
Public/Granted literature
- US20140273213A1 CONSERVED HBV AND HCV SEQUENCES USEFUL FOR GENE SILENCING Public/Granted day:2014-09-18
Information query
IPC分类:
